These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Physiological and pharmacologic regulation of bone resorption--a 1978 update. Raisz LG J Periodontol; 1979 Apr; 50(4 Spec No):3-6. PubMed ID: 222886 [No Abstract] [Full Text] [Related]
43. Editorial: Osteoclastic bone resorption and the hypercalcemia of cancer. Brewer HB N Engl J Med; 1974 Nov; 291(20):1081-2. PubMed ID: 4412968 [No Abstract] [Full Text] [Related]
44. The hypercalcemia of malignancy: pathogenesis and management. Mundy GR; Martin TJ Metabolism; 1982 Dec; 31(12):1247-77. PubMed ID: 6755168 [TBL] [Abstract][Full Text] [Related]
45. Pathogenesis of hypercalcemia in nude mice bearing a human renal carcinoma. Strewler GJ; Wronski TJ; Halloran BP; Miller SC; Leung SC; Williams RD; Nissenson RA Endocrinology; 1986 Jul; 119(1):303-10. PubMed ID: 3013591 [TBL] [Abstract][Full Text] [Related]
46. Forskolin sensitizes parathyroid hormone-induced cyclic AMP response, but not the bone resorptive effect, in mouse calvarial bones. Lerner UH; Ransjö M; Sahlberg K; Ljunggren O; Fredholm BB Bone Miner; 1989 Jan; 5(2):169-81. PubMed ID: 2537671 [TBL] [Abstract][Full Text] [Related]
47. [Metabolic bone diseases: malignancy-associated hypercalcemia]. Hamada M; Takeda R Nihon Rinsho; 1986 Nov; 44(11):2467-72. PubMed ID: 3546802 [No Abstract] [Full Text] [Related]
48. Hypercalcemia in breast cancer. Reassessment of the mechanism. Isales C; Carcangiu ML; Stewart AF Am J Med; 1987 Jun; 82(6):1143-7. PubMed ID: 3037897 [TBL] [Abstract][Full Text] [Related]
50. [Cyclic adenosine monophosphate and prostaglandins in oncology]. Bershteĭn LM; Dil'man VM Vopr Onkol; 1974; 20(3):105-20. PubMed ID: 4373912 [No Abstract] [Full Text] [Related]
51. Prostaglandin in calcium and bone metabolism. Dietrich JW; Raisz LG Clin Orthop Relat Res; 1975 Sep; (111):228-37. PubMed ID: 1098825 [TBL] [Abstract][Full Text] [Related]
52. Effects of cisplatin on parathyroid hormone- and human lung tumor-induced bone resorption. Abramson EC; Chang J; Mayer M; Kukla LJ; Shevrin DH; Lad TE; Buschman R; Kukreja SC J Bone Miner Res; 1988 Oct; 3(5):541-6. PubMed ID: 3195366 [TBL] [Abstract][Full Text] [Related]
53. Parathyroid hormone and thyrocalcitonin: their mode of action and regulation. Pak CY Ann N Y Acad Sci; 1971 Jul; 179():450-74. PubMed ID: 4328262 [No Abstract] [Full Text] [Related]
54. Hypercalcemia of cancer: an update. Goni MH; Tolis G Anticancer Res; 1993; 13(4):1155-60. PubMed ID: 8352538 [TBL] [Abstract][Full Text] [Related]
56. Prostaglandins as mediators of bone resorption in renal and breast tumours. Greaves M; Ibbotson KJ; Atkins D; Martin TJ Clin Sci (Lond); 1980 Mar; 58(3):201-10. PubMed ID: 7363561 [TBL] [Abstract][Full Text] [Related]
57. Rat osteogenic sarcoma cells:effects of some prostaglandins, their metabolites and analogues on cyclic AMP production. Atkins D; Martin TJ Prostaglandins; 1977 May; 13(5):861-71. PubMed ID: 194286 [TBL] [Abstract][Full Text] [Related]
59. Action of human tumoral factors as compared to parathyroid hormone (PTH) on cAMP production and sodium-dependent phosphate transport (NaPiT) in cultured renal epithelia with and without PTH receptors. Pizurki L; Rizzoli R; Caverzasio J; Bonjour JP Prog Clin Biol Res; 1988; 252():343-5. PubMed ID: 2831546 [No Abstract] [Full Text] [Related]
60. Overview of hypercalcemia of malignancy. Solimando DA Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]